Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 270Stomach Neoplasms 200Rectal Neoplasms 180Pancreatic Neoplasms 131Colonic Neoplasms 112Neoplasm Metastasis 74Esophageal Neoplasms 63Carcinoma, Hepatocellular 41Neoplasms 40Cholangiocarcinoma 36Adenocarcinoma Of Esophagus 32Adenocarcinoma 32Biliary Tract Neoplasms 25Liver Neoplasms 21Gallbladder Neoplasms 21Recurrence 18Gastrointestinal Neoplasms 18Lymphoma, Large B-Cell, Diffuse 17Peritoneal Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 16Esophageal Squamous Cell Carcinoma 14Locally Advanced Rectal Cancer 12Bile Duct Neoplasms 11Colorectal Cancer Metastatic 8Unspecified Adult Solid Tumor, Protocol Specific 7Ovarian Neoplasms 7Lymphoma, Extranodal NK-T-Cell 7Head and Neck Neoplasms 7Appendiceal Neoplasms 7

Interventions

ferric carboxymaltose 1Trastuzumab 1Oxaliplatin 1Fosfomycin 1Defecation 1Conservative Treatment 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Gastric Carcinoma × Oxaliplatin × Clear all
NCT05997524 2023-08-18

Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer.

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 2 Completed
60 enrolled
Gastrointestinal

Advanced Gastric Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡